title: Issues surrounding adjuvant chemotherapy for breast cancer during pregnancy.
authors.forename: B G
authors.initials: BG
authors.lastname: Peters
authors.forename: J J
authors.initials: JJ
authors.lastname: Bray
authors.forename: P
authors.initials: P
authors.lastname: Masidonski
authors.forename: S M
authors.initials: SM
authors.lastname: Mahon
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000328:Adult; D016223:Advance Directives; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001942:Breast Feeding; D001943:Breast Neoplasms / Q000188:drug therapy*; D003257:Consumer Product Safety; D003520:Cyclophosphamide / Q000008:administration & dosage; D003657:Decision Making; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D007258:Informed Consent; D009769:Object Attachment; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D018570:Risk Assessment
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide